Skip to main content
. 2018 Apr 4;2018(4):CD006349. doi: 10.1002/14651858.CD006349.pub3
Methods Two‐arm randomised controlled trial.
Participants Sample size = 84
Inclusion criteria
  • Elderly osteoporotic thoracolumbar compression fractures

  • Imaging diagnosis of osteoporotic thoracolumbar VCFs

  • Spinal cord or cauda equina nerve were not significantly compressed

  • Without systemic symptoms such as problems with urination

  • Can take care of themselves

  • No other systemic diseases, such as infectious diseases or haemorrhagic diseases


Exclusion criteria
  • Patients with forced traction and spinal rotation injury

  • Spine burst fracture

  • Non‐new osteoporotic compression fractures

  • Imaging examination showing more than 70% compression of the vertebral body

Interventions
  • Vertebroplasty with bone cement injection

  • Bed rest and conservative treatment

Outcomes Follow‐up time was 3 months and at 12‐54 months (average of 34.7 months for final follow‐up)
Study outcomes
VAS score
ODI and vertebral height
Study name Bone cement injection as vertebral augmentation therapy for osteoporotic vertebral compression fractures. [Chinese]
Starting date Jan 2010
Contact information Chen Junping, Department of Orthopedics, the Fifth Affiliated Hospital of Zunyi Medical College, Zhuhai 519100, Guangdong Province, China
Notes Trial not registered at clinical trials.gov website
Published in Chinese, awaiting translation.